Immunogenicity of rVSVAG-ZEBOV-GP Ebola vaccine (ERVEBO (R)) in African clinical trial participants by age, sex, and baseline GP-ELISA titer: A post hoc analysis of three Phase 2/3 trials q

Simon, JK; Kennedy, SB; Mahon, BE; Dubey, SA; Grant-Klein, RJ; Liu, K; Hartzel, J; Coller, BAG; Welebob, C; Hanson, ME; Grais, RF

Coller, BAG (通讯作者)，Merck & Co Inc, 123 East Lincoln Ave, Rahway, NJ 07065 USA.

VACCINE, 2022; 40 (46): 6599

Abstract

Background: ERVEBO (R), a live recombinant vesicular stomatitis virus (VSV) vaccine containing the Zaire ebolavirus glycoprotein (GP) in place of the ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索